Quarterly snapshots from biopharma companies with marketed products, including: Amicus, Sarepta.

Quarterly snapshots from biopharma companies with marketed products, including: Biomarin, PTC, Radius.

Quarterly snapshots from biopharma companies with marketed products, including: Acadia, Agios, Amarin, Coherus, Intercept, Intra-Cellular, Moderna.

Quarterly snapshots from biopharma companies with marketed products, including: Halozyme, Jazz, United.

Quarterly snapshots from biopharma companies with marketed products, including: Clovis, Epizyme.

Quarterly snapshots from biopharma companies with marketed products, including: Ironwood.

Quarterly snapshots from biopharma companies with marketed products, including: Antengene, Forus, Karyopharm.

Quarterly snapshots from biopharma companies with marketed products, including: GW.

Immunogen Inc. leads a busy earnings season with numbers that pushed the stock (NASDAQ:IMGN) 30.3% higher on Feb. 12. The antibody-drug conjugates developer posted revenues of $132.3 million for 2020 compared to its $82.3 million in revenues for 2019, a 62.2% increase.

Quarterly snapshots from biopharma companies with marketed products, including: Alkermes, Alnylam, Exelixis, Karyopharm, Vanda.